EMA has published an overview of its key recommendations of 2021 regarding the authorisation and safety monitoring of veterinary medicines.
A selection of these recommendations can be found in the veterinary medicines highlights document published today.
You have received this mail because you have registered in the EMA stakeholders database and subscribed to receive this kind of information. However, if you no longer wish to receive such communications from us, please send an email to StakeholdersDB@ema.europa.eu to unsubscribe.
We would be grateful if you could disseminate this email to anyone else who might be interested in this information.
With kind regards,
Public and Stakeholders Engagement Department
Stakeholders and Communication Division
European Medicines Agency